OBT(OBT)
OBT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $134M | $145M |
| Low | $134M | $145M |
| High | $134M | $145M |
| EBITDA Avg | $43M | $46M |
| Low | $43M | $46M |
| High | $43M | $46M |
| EBIT Avg | $41M | $44M |
| Low | $41M | $44M |
| High | $41M | $44M |
| Net Income Avg | $43M | $48M |
| Low | $42M | $48M |
| High | $43M | $48M |
| EPS Avg | $3.40 | $3.83 |
| Low | $3.39 | $3.83 |
| High | $3.40 | $3.84 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $34M | $35M | $35M | $36M | $37M | $38M |
| Low | $34M | $34M | $34M | $36M | $37M | $37M |
| High | $34M | $35M | $35M | $36M | $37M | $38M |
| EBITDA Avg | $11M | $11M | $11M | $11M | $12M | $12M |
| Low | $11M | $11M | $11M | $11M | $12M | $12M |
| High | $11M | $11M | $11M | $12M | $12M | $12M |
| EBIT Avg | $10M | $11M | $11M | $11M | $11M | $11M |
| Low | $10M | $10M | $10M | $11M | $11M | $11M |
| High | $10M | $11M | $11M | $11M | $11M | $12M |
| Net Income Avg | $12M | $12M | $12M | $13M | $13M | $13M |
| Low | $11M | $12M | $12M | $13M | $13M | $13M |
| High | $12M | $12M | $12M | $13M | $13M | $14M |
| EPS Avg | $0.86 | $0.90 | $0.88 | $0.95 | $1.00 | $1.01 |
| Low | $0.85 | $0.89 | $0.88 | $0.94 | $0.99 | $1.00 |
| High | $0.88 | $0.91 | $0.89 | $0.96 | $1.01 | $1.02 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |